Class information for:
Level 1: AMPHOTERICIN B//POLYENE ANTIBIOTICS//AMPHOTERICIN B LIPID COMPLEX

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3282 2021 31.8 67%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
156 3       MYCOSES//MYCOLOGY//CANDIDA ALBICANS 62026
55 2             CANDIDA ALBICANS//CANDIDA//ASPERGILLOSIS 29629
3282 1                   AMPHOTERICIN B//POLYENE ANTIBIOTICS//AMPHOTERICIN B LIPID COMPLEX 2021

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMPHOTERICIN B authKW 2357519 27% 29% 540
2 POLYENE ANTIBIOTICS authKW 261108 2% 52% 33
3 AMPHOTERICIN B LIPID COMPLEX authKW 244305 1% 56% 29
4 LIPOSOMAL AMPHOTERICIN B authKW 194680 3% 22% 59
5 AMBISOME authKW 192662 1% 49% 26
6 AMPHOTERICIN B COLLOIDAL DISPERSION authKW 159566 1% 81% 13
7 ABELCET authKW 145025 1% 80% 12
8 ABLC authKW 140610 1% 85% 11
9 AMPHOTERICIN B DEOXYCHOLATE authKW 134582 1% 64% 14
10 AMPHOTERICIN B DERIVATIVES authKW 122367 0% 90% 9

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 11191 44% 0% 885
2 Microbiology 7378 26% 0% 524
3 Infectious Diseases 4967 15% 0% 309
4 Biophysics 1395 10% 0% 211
5 Mycology 1241 3% 0% 67
6 Immunology 403 9% 0% 173
7 Biochemistry & Molecular Biology 283 14% 0% 289
8 Chemistry, Medicinal 227 4% 0% 79
9 Materials Science, Biomaterials 78 1% 0% 26
10 Chemistry, Multidisciplinary 78 7% 0% 147

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IMMUNOCOMPROMISED HOST SECT 59582 1% 13% 30
2 CONSORTIUM PARASIT DRUG DEV 45322 0% 100% 3
3 SISTEMAS DISPERSOS LASID 31468 0% 42% 5
4 PHARMACEUT TECHNOL BIOCHEM 30396 1% 7% 28
5 ACUTE CARE ANIM UNIT 30215 0% 100% 2
6 EXTERNAL ACT 30215 0% 100% 2
7 BIODELIVERY SCI INC 27191 0% 60% 3
8 DRUGS COSMET 20142 0% 67% 2
9 FARM DFAR 20142 0% 67% 2
10 UA 851 20142 0% 67% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31683 11% 1% 223
2 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 15340 6% 1% 113
3 BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 3622 2% 1% 39
4 MYCOSES 3119 1% 1% 25
5 CLINICAL INFECTIOUS DISEASES 1819 2% 0% 40
6 MEDICAL MYCOLOGY 1379 1% 1% 14
7 CHEMOTHERAPY 1314 1% 1% 15
8 BIOCHIMICA ET BIOPHYSICA ACTA 1185 2% 0% 49
9 INTERNATIONAL JOURNAL OF PHARMACEUTICS 1175 2% 0% 36
10 CANCER DRUG DELIVERY 1166 0% 3% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 AMPHOTERICIN B 2357519 27% 29% 540 Search AMPHOTERICIN+B Search AMPHOTERICIN+B
2 POLYENE ANTIBIOTICS 261108 2% 52% 33 Search POLYENE+ANTIBIOTICS Search POLYENE+ANTIBIOTICS
3 AMPHOTERICIN B LIPID COMPLEX 244305 1% 56% 29 Search AMPHOTERICIN+B+LIPID+COMPLEX Search AMPHOTERICIN+B+LIPID+COMPLEX
4 LIPOSOMAL AMPHOTERICIN B 194680 3% 22% 59 Search LIPOSOMAL+AMPHOTERICIN+B Search LIPOSOMAL+AMPHOTERICIN+B
5 AMBISOME 192662 1% 49% 26 Search AMBISOME Search AMBISOME
6 AMPHOTERICIN B COLLOIDAL DISPERSION 159566 1% 81% 13 Search AMPHOTERICIN+B+COLLOIDAL+DISPERSION Search AMPHOTERICIN+B+COLLOIDAL+DISPERSION
7 ABELCET 145025 1% 80% 12 Search ABELCET Search ABELCET
8 ABLC 140610 1% 85% 11 Search ABLC Search ABLC
9 AMPHOTERICIN B DEOXYCHOLATE 134582 1% 64% 14 Search AMPHOTERICIN+B+DEOXYCHOLATE Search AMPHOTERICIN+B+DEOXYCHOLATE
10 AMPHOTERICIN B DERIVATIVES 122367 0% 90% 9 Search AMPHOTERICIN+B+DERIVATIVES Search AMPHOTERICIN+B+DERIVATIVES

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 KAMINSKI, DM , (2014) RECENT PROGRESS IN THE STUDY OF THE INTERACTIONS OF AMPHOTERICIN B WITH CHOLESTEROL AND ERGOSTEROL IN LIPID ENVIRONMENTS.EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS. VOL. 43. ISSUE 10-11. P. 453 -467 115 85% 17
2 BRAJTBURG, J , BOLARD, J , (1996) CARRIER EFFECTS ON BIOLOGICAL ACTIVITY OF AMPHOTERICIN B.CLINICAL MICROBIOLOGY REVIEWS. VOL. 9. ISSUE 4. P. 512-& 145 91% 203
3 BAGINSKI, M , CZUB, J , (2009) AMPHOTERICIN B AND ITS NEW DERIVATIVES - MODE OF ACTION.CURRENT DRUG METABOLISM. VOL. 10. ISSUE 5. P. 459 -469 128 79% 55
4 TORRADO, JJ , ESPADA, R , BALLESTEROS, MP , TORRADO-SANTIAGO, S , (2008) AMPHOTERICIN B FORMULATIONS AND DRUG TARGETING.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 97. ISSUE 7. P. 2405-2425 110 77% 108
5 ZIA, Q , AZHAR, A , KAMAL, MA , ALIEV, G , OWAIS, M , ASHRAF, GM , (2016) SUPER AGGREGATED FORM OF AMPHOTERICIN B: A NOVEL WAY TO INCREASE ITS THERAPEUTIC INDEX.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 7. P. 792 -803 81 86% 0
6 LOO, AS , MUHSIN, SA , WALSH, TJ , (2013) TOXICOKINETIC AND MECHANISTIC BASIS FOR THE SAFETY AND TOLERABILITY OF LIPOSOMAL AMPHOTERICIN B.EXPERT OPINION ON DRUG SAFETY. VOL. 12. ISSUE 6. P. 881 -895 81 80% 9
7 HAMILL, R , (2013) AMPHOTERICIN B FORMULATIONS: A COMPARATIVE REVIEW OF EFFICACY AND TOXICITY.DRUGS. VOL. 73. ISSUE 9. P. 919-934 59 74% 64
8 KARIMZADEH, I , KHALILI, H , FARSAEI, S , DASHTI-KHAVIDAKI, S , SAGHEB, MM , (2013) ROLE OF DIURETICS AND LIPID FORMULATIONS IN THE PREVENTION OF AMPHOTERICIN B-INDUCED NEPHROTOXICITY.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 69. ISSUE 7. P. 1351-1368 68 82% 5
9 ARIKAN, S , REX, JH , (2001) LIPID-BASED ANTIFUNGAL AGENTS: CURRENT STATUS.CURRENT PHARMACEUTICAL DESIGN. VOL. 7. ISSUE 5. P. 393 -415 88 80% 28
10 VYAS, SP , GUPTA, S , (2006) OPTIMIZING EFFICACY OF AMPHOTERICIN B THROUGH NANOMODIFICATION.INTERNATIONAL JOURNAL OF NANOMEDICINE. VOL. 1. ISSUE 4. P. 417-432 69 78% 28

Classes with closest relation at Level 1


Rank Class id link
1 5768 MICAFUNGIN//CASPOFUNGIN//ECHINOCANDINS
2 781 INVASIVE ASPERGILLOSIS//ASPERGILLOSIS//INVASIVE FUNGAL INFECTION
3 19186 REDUCTION DIASTEREOSELECTIVE//ALDOL PRODUCTS//POLYENE MACROLIDE
4 36881 POLYVINYLPYRROLIDONE 10000//POLYETHYLENEGLYCOL 1500//DISPOSAL OF DRUGS
5 16989 FLUCONAZOLE PROPHYLAXIS//CONGENITAL CANDIDIASIS//CANDIDA
6 21419 NOVEL DRUG VACCINE DELIVERY SYST IL//LIPOSOMAL ANTIBIOTIC//ZINC CITRATE PARTICLES
7 9484 FLUCONAZOLE//MICRODILUTION TEST//SUSCEPTIBILITY TESTING
8 36772 PENCLOMEDINE//BOETIUS THERMOMICROSCOPY//THERMOTROP LIQUID CRYSTAL
9 3390 LEISHMANIA//MILTEFOSINE//ANTIMONY RESISTANCE
10 8574 VORICONAZOLE//POSACONAZOLE//HYDROXYITRACONAZOLE

Go to start page